Oncology Institute PE Ratio 2020-2025 | TOI

Current and historical p/e ratio for Oncology Institute (TOI) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Oncology Institute PE ratio as of May 23, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Oncology Institute PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-23 3.02 0.00
2025-03-31 1.14 $-0.49 0.00
2024-12-31 0.31 $-0.71 0.00
2024-09-30 0.33 $-0.78 0.00
2024-06-30 0.46 $-0.79 0.00
2024-03-31 1.58 $-0.81 0.00
2023-12-31 2.04 $-0.92 0.00
2023-09-30 1.40 $-0.86 0.00
2023-06-30 0.55 $-0.84 0.00
2023-03-31 0.68 $-0.71 0.00
2022-12-31 1.65 $-0.17 0.00
2022-09-30 4.63 $-0.17 0.00
2022-06-30 5.06 0 0.00
2022-03-31 7.13 $0.06 118.83
2021-12-31 9.75 $-0.15 0.00
2021-09-30 9.94 0 0.00
2021-06-30 9.95 0 0.00
2021-03-31 9.96 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $0.228B $0.393B
The Oncology Institute is involved in providing value-based oncology care. The Oncology Institute, formerly known as DFP Healthcare Acquisitions Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $132.070B 24.77
Elevance Health (ELV) United States $84.109B 10.85
CVS Health (CVS) United States $76.951B 9.56
Cencora (COR) United States $56.664B 19.71
DiDi Global (DIDIY) China $22.591B 34.29
Natera (NTRA) United States $20.935B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.529B 0.00
Solventum (SOLV) United States $12.251B 12.97
CochLear (CHEOY) Australia $11.298B 0.00
Revvity (RVTY) United States $10.529B 18.12
ICON (ICLR) Ireland $10.336B 9.61
Viatris (VTRS) United States $9.730B 3.34
Doximity (DOCS) United States $9.525B 44.37
Avantor (AVTR) United States $8.647B 12.56
HealthEquity (HQY) United States $8.564B 42.13
Medpace Holdings (MEDP) United States $8.476B 22.51
Sonic Healthcare (SKHHY) Australia $8.176B 0.00
Charles River Laboratories (CRL) United States $6.716B 13.16
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.048B 37.47
Bausch + Lomb (BLCO) Canada $3.990B 23.52
Sotera Health (SHC) United States $3.452B 19.61
Surgery Partners (SGRY) United States $2.922B 38.00
Alignment Healthcare (ALHC) United States $2.865B 0.00
Concentras Parent (CON) United States $2.710B 15.66
Organon (OGN) United States $2.259B 2.40
Ardent Health Partners (ARDT) United States $2.091B 8.91
GeneDx Holdings (WGS) United States $2.043B 78.68
Premier (PINC) United States $1.899B 14.41
Progyny (PGNY) United States $1.759B 38.72
PACS (PACS) United States $1.497B 0.00
GoodRx Holdings (GDRX) United States $1.336B 26.71
Teladoc Health (TDOC) United States $1.195B 0.00
Pediatrix Medical (MD) United States $1.165B 8.86
Establishment Labs Holdings (ESTA) $1.059B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.944B 14.74
Agilon Health (AGL) United States $0.919B 0.00
Nutex Health (NUTX) United States $0.890B 13.45
AMN Healthcare Services Inc (AMN) United States $0.795B 7.44
QDM (QDMI) Hong Kong, SAR China $0.743B 0.00
Embecta (EMBC) United States $0.626B 4.22
InnovAge Holding (INNV) United States $0.531B 0.00
LifeMD (LFMD) United States $0.524B 0.00
Enhabit (EHAB) United States $0.518B 42.58
Auna S.A (AUNA) Luxembourg $0.492B 11.08
SBC Medicals (SBC) United States $0.471B 0.00
Sonida Senior Living (SNDA) United States $0.462B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.405B 0.00
Performant Healthcare (PHLT) United States $0.215B 0.00
Beauty Health (SKIN) United States $0.202B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.137B 22.33
OncoCyte (OCX) United States $0.096B 0.00
So-Young (SY) China $0.087B 0.00
Sera Prognostics (SERA) United States $0.066B 0.00
Ascend Wellness Holdings (AAWH) United States $0.061B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Biodesix (BDSX) United States $0.050B 0.00
Pheton Holdings (PTHL) China $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Basel Medical Group (BMGL) Singapore $0.025B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00